Ocugen (OCGN) Cash from Financing Activities (2014 - 2026)

Ocugen (OCGN) reported Cash from Financing Activities of $35.0 million for Q1 2026, up 2909.96% on a YoY basis from $1.2 million in Q1 2025, and up 1749100.0% quarter-over-quarter from $2000.0 in Q4 2025.

Ocugen (OCGN) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Ocugen has reported Cash from Financing Activities for 13 years, with the latest figure at $35.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 2909.96% year-over-year to $35.0 million; the trailing twelve-month figure through Mar 2026 stood at $53.6 million (down 16.0% YoY), and the FY2025 full-year result was $17.3 million, down 73.28% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $35.0 million, up from $2000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $50.1 million in Q1 2022, with the low at -$1.2 million in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $11.6 million across 5 years, with a median of $962000.0 in 2022.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 188475.0% — and 2025, when it sank 758.62%.
  • Ocugen's Cash from Financing Activities stood at $8.2 million in 2022, then sank by 99.8% to $16000.0 in 2023, then surged by 188475.0% to $30.2 million in 2024, then sank by 99.99% to $2000.0 in 2025, then jumped by 1749100.0% to $35.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $35.0 million (Q1 2026), $2000.0 (Q4 2025), and $18.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Ocugen 411.07 Mn 411.07 Mn - 34.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.98 Mn
Mar 31, 2026 34.98 Mn
Dec 31, 2025 2,000.00
Dec 31, 2025 2,000.00
Sep 30, 2025 18.51 Mn
Sep 30, 2025 18.51 Mn
Jun 30, 2025 61,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 -1.25 Mn
Mar 31, 2025 -1.25 Mn
Dec 31, 2024 30.17 Mn
Dec 31, 2024 30.17 Mn
Sep 30, 2024 34.79 Mn
Sep 30, 2024 34.79 Mn
Jun 30, 2024 45,000.00
Jun 30, 2024 45,000.00
Mar 31, 2024 -145,000.00
Mar 31, 2024 -145,000.00
Dec 31, 2023 16,000.00
Dec 31, 2023 16,000.00